Gainers Buzz: Concho Resources Inc, EMC Corporation, Hewlett-Packard Company, Trius Therapeutics

Lakeway, NY -- (SBWIRE) -- 03/15/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Concho Resources Inc. (NYSE:CXO) shares gained 2.90% to $96.82. CXO’s stock was upgraded by research analysts at Iberia Capital to a “sector perform” rating in a report released on Feb. 22.

Additionally, the company announced its earnings results on Feb. 20. The company reported $0.72 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.01 by $0.29. The company had revenue of $477.53 million for the quarter, compared to the consensus estimate of $526.42 million.

Is CXO a Still a Buy after the Solid momentum? Let’s Find out Here

EMC Corporation(NYSE:EMC) shares climbed 2.89% to $25.62. The company, on Mar. 7, announced that it is providing 2.8 petabytes of storage to help the Vatican Apostolic Library digitize its entire catalogue of historic manuscripts and incunabula (a book or pamphlet printed before 1501).

Additionally, the company, on Mar. 5, announced the EMC® Xtrem(TM) Family of Flash-optimized server and storage products and introduced a new line of EMC XtremSF(TM) PCIe-based Flash cards that dramatically accelerate application performance. With the addition of XtremSF, EMC continues delivering the industry's only best-of-breed portfolio of Flash products.

Is EMC a Strong Buying Opportunity After The Recent Slump? Find out Here

Hewlett-Packard Company (NYSE:HPQ) shares increased 2.86% to $21.93. ISI Group analyst Brian Marshall reiterated his Neutral rating on HPQ on Mar. 13.

Additionally, the company, on Feb. 21, posted first quarter net income of $1.2 billion, or 63 cents a share. Adjusted earnings for the recent quarter came in at 82 cents a share. Revenue fell 6% to $28.4 billion. Analysts were expecting adjusted earnings of 71 cents a share on revenue of $27.9 billion.

Should HPQ Buy After The Recent Movement? Let’s Find out Here

Trius Therapeutics, Inc.(NASDAQ:TSRX) shares increased 2.84% to $6.89. The company on March 12, reported a net loss of $14.2 million versus a net loss of $12.5 million in the comparable period in 2011. For the year ended December 31, 2012, it reported a net loss of $53.9 million compared to $18.3 million for the same period in 2011. Revenues for the three months ended December 31, 2012 were $5.2 million compared to $5.0 million for the same period in 2011. For the year ended December 31, 2012, revenues were $27.2 million compared to $41.0 million for the same period in 2011.

Should TSRX Buy After The Recent Movement? Let’s Find out Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.